Detailed answers about HARBOUR AND SHORE CLINICAL SERVICES LIMITED, including incorporation, status, business activity, and accounts information.
When was HARBOUR AND SHORE CLINICAL SERVICES LIMITED founded?
HARBOUR AND SHORE CLINICAL SERVICES LIMITED was officially incorporated on 2 March 2026 and is registered under company number 17064362. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is HARBOUR AND SHORE CLINICAL SERVICES LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of HARBOUR AND SHORE CLINICAL SERVICES LIMITED?
HARBOUR AND SHORE CLINICAL SERVICES LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does HARBOUR AND SHORE CLINICAL SERVICES LIMITED do?
HARBOUR AND SHORE CLINICAL SERVICES LIMITED operates in the following sector: 84120 - Regulation of health care, education, cultural and other social services, not incl. social security. This provides insight into the company's primary business activity and industry focus.
What is HARBOUR AND SHORE CLINICAL SERVICES LIMITED's registered address?
The registered office address of HARBOUR AND SHORE CLINICAL SERVICES LIMITED is 37 Burton Road, Ashby-De-La-Zouch, England, LE65 2LF. This is the official address filed with Companies House for legal and statutory correspondence.
Is HARBOUR AND SHORE CLINICAL SERVICES LIMITED financially stable?
Financial accounts for HARBOUR AND SHORE CLINICAL SERVICES LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.